ID
44766
Beschreibung
Documentation part: Adverse Events & Clinical Outcome Evaluation A Randomised, Observer-blind, Multicentre, Non-inferiority, Comparative, Phase III Study of the Safety and Efficacy of Topical 1% SB-275833 Ointment, Applied Twice Daily for 5 Days, versus Topical 2% Sodium Fusidate Ointment Applied Three Times Daily for 7 Days in the Treatment of Adult and Paediatric Subjects with Impetigo. ClinicalTrials.gov Identifier: NCT00133874 Other Study ID Numbers: TOC100224 Responsible Party: GlaxoSmithKline
Stichworte
Versionen (4)
- 27.06.16 27.06.16 -
- 27.06.16 27.06.16 -
- 13.04.21 13.04.21 - Dr. rer. medic Philipp Neuhaus
- 17.11.21 17.11.21 -
Rechteinhaber
GlaxoSmithKline
Hochgeladen am
17. November 2021
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY-NC 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Adverse Events & Clinical Outcome Evaluation Topical SB-275833 Ointment 1% For The Treatment Of Impetigo NCT00133874
Adverse Events & Clinical Outcome Evaluation Topical SB-275833 Ointment 1% For The Treatment Of Impetigo NCT00133874
Beschreibung
Clinical Outcome Determination (OUT)
Beschreibung
Clinical success
Datentyp
text
Alias
- UMLS CUI [1]
- C0085565 (Outcome Assessment, Health Care)
Beschreibung
Clinical recurrence
Datentyp
text
Alias
- UMLS CUI [1]
- C0679254 (Disease recurrence)
Beschreibung
If
Datentyp
text
Alias
- UMLS CUI [1,1]
- C3640841 (Clinical Failure)
- UMLS CUI [1,2]
- C1402294 (Primary Lesion)
- UMLS CUI [2,1]
- C3640841 (Clinical Failure)
- UMLS CUI [2,2]
- C1519215 (Secondary Lesion)
Beschreibung
Date of recurrence
Datentyp
date
Maßeinheiten
- DDMONYYYY
Alias
- UMLS CUI [1]
- C0807712 (Date of Recurrence)
Beschreibung
Unable to determine clinical outcome, please specify:
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0085565 (Outcome Assessment, Health Care)
- UMLS CUI [1,2]
- C3845108 (Unclear or unknown)
- LOINC
- LA10109-9
Ähnliche Modelle
Adverse Events & Clinical Outcome Evaluation Topical SB-275833 Ointment 1% For The Treatment Of Impetigo NCT00133874
C1522314 (UMLS CUI [2])
C1301931 (UMLS CUI [2])
C0877248 (UMLS CUI [1,2])
C0877248 (UMLS CUI [1,2])
C1710056 (UMLS CUI [1,2])
C3641099 (UMLS CUI [1,2])
C1402294 (UMLS CUI [1,2])
C3640841 (UMLS CUI [2,1])
C1519215 (UMLS CUI [2,2])
C3845108 (UMLS CUI [1,2])
Keine Kommentare